跳至主要内容
临床试验/NCT05351749
NCT05351749已完成不适用

Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use

University of Michigan1 个研究点 分布在 1 个国家目标入组 306 人开始时间: 2022年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
306
试验地点
1
主要终点
The Number (Proportion) of Notifications (in the Existing-prescription Notification Conditions) That Are Addressed Within 7 Days.

研究概览

简要总结

The researchers hypothesize that existing-prescription notifications directed to pharmacists are more likely to lead to a prescription change than existing-prescription notifications directed to prescribers. Furthermore, the researchers hypothesize that the availability of a pharmacist referral option is associated with a higher rate of prescription changes for initial-prescription alerts that are directed to the prescriber at the time of initial-prescribing errors.

Findings from this project will establish a framework for implementing prescriber-pharmacist collaboration for high risk medications, including anticoagulants

详细描述

Please note that the 3rd and 4th outcome measures are conditional on the outcomes of the 1st and 2nd outcome measures respectively.

Please note that enrollment of 300 will provide sufficient power to study.

Study data was obtained through data downloads and not from individual participant interactions. Final data collection for all outcomes took place on Dec 15, 2024.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •Prescribers:
  • •Inclusion Criteria:
  • •Michigan Medicine provider with prescribing privileges
  • •Providers in ambulatory care settings
  • •Prescribe DOAC to patients 18 years and older

排除标准

  • •Providers in inpatient settings
  • •Providers who are members of the study team

研究组 & 干预措施

New-prescription Alert / Existing-prescription notification to prescriber

Experimental

干预措施: New-prescription Alert (Behavioral)

New-prescription Alert / Existing-prescription notification to prescriber

Experimental

干预措施: Existing-prescription notification to prescriber (Behavioral)

New-prescription Alert w/ referral option/ Existing-prescription notification to prescriber

Experimental

干预措施: New-prescription Alert with referral option (Behavioral)

New-prescription Alert w/ referral option/ Existing-prescription notification to prescriber

Experimental

干预措施: Existing-prescription notification to prescriber (Behavioral)

New-prescription Alert/ Existing-prescription notification to pharmacist

Experimental

干预措施: New-prescription Alert (Behavioral)

New-prescription Alert/ Existing-prescription notification to pharmacist

Experimental

干预措施: Existing-prescription notification to pharmacist (Behavioral)

New-prescription Alert w/ referral option/ Existing-prescription notification to pharmacist

Experimental

干预措施: New-prescription Alert with referral option (Behavioral)

New-prescription Alert w/ referral option/ Existing-prescription notification to pharmacist

Experimental

干预措施: Existing-prescription notification to pharmacist (Behavioral)

结局指标

主要结局

The Number (Proportion) of Notifications (in the Existing-prescription Notification Conditions) That Are Addressed Within 7 Days.

时间窗: Up to 7 days

Existing-prescription notification conditions = Prescriber notification \& Pharmacist notification The number of notifications (in the existing-prescription notification conditions) that are addressed within 7 days/ total number of notifications

次要结局

  • Change in Effect Size for the Initial Alert Over Time(Month 0 to 19 months)
  • The Number (Proportion) of Alerts (in the Newly Prescribed DOAC Alert Conditions) That Are Addressed Within 7 Days.(Up to 7 days)
  • Change in Effect Size for the Existing-prescription Notification Over Time(Month 0 to 19 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Geoffrey Barnes

Assistant Professor of Internal Medicine

University of Michigan

研究点 (1)

Loading locations...

相似试验